water soluble drug compounds. The aim of the present work was to enhance dissolution and oral bioavailability of poorly water-soluble celecoxib (CXB) by preparing stable CXB nanoparticles using a promising method, meanwhile, investigate the mechanism of increasing dissolution of CXB. Methods: CXB nanoparticles were produced by combining the antisolvent precipitation and high pressure homogenization (HPH) approaches in the presence of HPMC E5 and SDS (2:1, w/w). Then the CXB nanosuspensions were converted into dry powders by spray-drying. The effect of process variables on particle size and physical state of CXB were investigated. The physicochemical properties of raw CXB and CXB nanoparticles were characterized by scanning electron microsco...
The present study compares energetics of wetting behavior of crystalline and amorphous forms of a po...
Celecoxib (CXB) is a poorly aqueous solubility sulfonamide non-steroidal anti-inflammatory drug (NSA...
An attractive approach to increase the aqueous apparent solubility of poorly soluble drugs is to for...
Poor solubility and dissolution of hydrophobic drugs have become a major challenge in pharmaceutical...
This study aims at developing and evaluating reconstitutable dry suspension (RDS) improved for disso...
We aimed to develop a novel celecoxib (CXB)-loaded nanosuspension with improved dissolution and oral...
Celecoxib (CXB) is a Biopharmaceutical Classification System (BCS) Class II molecule with high perme...
Introduction: Celecoxib is a weakly acidic drug and has low aqueous solubility (3–7 μg/ml). Low solu...
Oral route has been the most convenient mode for the drug delivery. It has been received more attent...
The aim of this study was to develop celecoxib-polyvinylpyrrolidone (PVP) solid dispersion nanoparti...
The aim of this study was to develop celecoxib (CLX) -polyvinylpyrrolidone (PVP) solid dispersion na...
To develop a novel celecoxib (CXB)-loaded drug delivery system, numerous nanosuspensions were prepar...
The present research investigates the enhancement of the dissolution rate of celecoxib by using spra...
Background: Celecoxib is a non-steroidal anti-inflammatory drug used extensively in the treatment of...
The present study deals with characterization of dispersions of a poorly water-soluble drug, celecox...
The present study compares energetics of wetting behavior of crystalline and amorphous forms of a po...
Celecoxib (CXB) is a poorly aqueous solubility sulfonamide non-steroidal anti-inflammatory drug (NSA...
An attractive approach to increase the aqueous apparent solubility of poorly soluble drugs is to for...
Poor solubility and dissolution of hydrophobic drugs have become a major challenge in pharmaceutical...
This study aims at developing and evaluating reconstitutable dry suspension (RDS) improved for disso...
We aimed to develop a novel celecoxib (CXB)-loaded nanosuspension with improved dissolution and oral...
Celecoxib (CXB) is a Biopharmaceutical Classification System (BCS) Class II molecule with high perme...
Introduction: Celecoxib is a weakly acidic drug and has low aqueous solubility (3–7 μg/ml). Low solu...
Oral route has been the most convenient mode for the drug delivery. It has been received more attent...
The aim of this study was to develop celecoxib-polyvinylpyrrolidone (PVP) solid dispersion nanoparti...
The aim of this study was to develop celecoxib (CLX) -polyvinylpyrrolidone (PVP) solid dispersion na...
To develop a novel celecoxib (CXB)-loaded drug delivery system, numerous nanosuspensions were prepar...
The present research investigates the enhancement of the dissolution rate of celecoxib by using spra...
Background: Celecoxib is a non-steroidal anti-inflammatory drug used extensively in the treatment of...
The present study deals with characterization of dispersions of a poorly water-soluble drug, celecox...
The present study compares energetics of wetting behavior of crystalline and amorphous forms of a po...
Celecoxib (CXB) is a poorly aqueous solubility sulfonamide non-steroidal anti-inflammatory drug (NSA...
An attractive approach to increase the aqueous apparent solubility of poorly soluble drugs is to for...